Xeris Pharmaceuticals | XERS - Trade Creditors


Xeris Pharmaceuticals reported $9.34M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Celltrion KRW 88.58B 9.9B Mar/2026
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 6.39M 1.12M Jun/2026
Divis Laboratories Ltd INR 12.11B 1.71B Mar/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Kangmei Pharma CNY 2.46B 153.5M Mar/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Organigram Holdings CAD 73.14M 2.06M Mar/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pacira USD 17.51M 3.5M Jun/2026
Perrigo USD 400.4M 34.4M Jun/2026
Pharma Mar EUR 38.93M 4.9M Jun/2026
Qiagen NV USD 79.08M 785K Jun/2026
Sartorius EUR 329.1M 16.2M Jun/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Supernus Pharmaceuticals USD 5.59M 4.58M Jun/2026
Tilray USD 114.5M 3.69M Sep/2025
Zealand Pharma A/S 171M 175.6M Mar/2026
Zz Pientze Pharmaceu CNY 457.05M 59.09M Mar/2026